PathoPhysiology Chapter 28

26
Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc. CHAPTER 28 ACUTE RENAL FAILURE AND CHRONIC KIDNEY DISEASE

Transcript of PathoPhysiology Chapter 28

Page 1: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHAPTER 28ACUTE RENAL FAILURE AND CHRONIC KIDNEY DISEASE

Page 2: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE

Etiology and Pathophysiology• ARF: an abrupt reduction in renal function

producing an accumulation of waste materials in the blood

• May be due to aging, associated with comorbidities, or due to insults to the kidney

• Renal function monitored by serum creatinine and creatinine clearance

Page 3: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

• Retention of metabolic wastes (azotemia/uremia) monitored by BUN, produces widespread systemic effects (uremic syndrome)

Page 4: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Prerenal Acute Renal Failure• Due to conditions that impair renal blood flow,

such as hypovolemia, hypotension, cardiac failure, and renal artery obstruction

• Characterized by low GFR, oliguria, high urine specific gravity and osmolality, and low urine sodium

• S/S of fluid overload are present• Prolonged prerenal ARF leads to intrarenal RF

Page 5: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Page 6: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Postrenal Acute Renal Failure• Due to obstruction within the urinary collecting

system distal to the kidney; elevated pressure in Bowman capsule; impedes glomerular filtration

• Clinical findings based on duration of the obstruction

• Prolonged postrenal ARF leads to intrarenal RF

Page 7: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Page 8: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Intrarenal Acute Renal Failure• Due to a primary dysfunction of the nephrons• Most often due to problem within the renal

tubules resulting in acute tubular necrosis; may also occur with glomerular, vascular, or interstitial etiologies

• ATN may occur with nephrotoxic or ischemic insults; clinical manifestations depend on stage of ATN

Page 9: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Page 10: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Clinical Presentation of Acute TubularNecrosis: Oliguric Stage• Characterized by oliguria and progressive uremia;

decreased GFR; hypervolemia• May last 1 to 2 weeks• Dialysis may be required

Page 11: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Clinical Presentation of Acute TubularNecrosis: Diuretic Stage• Urine volume increases, but tubular function

remains impaired and azotemia continues• May last 2 to 10 days

Page 12: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Clinical Presentation of Acute TubularNecrosis: Recovery Stage• Characterized by gradual normalization of serum

creatinine and BUN• May last up to 12 months• Often a degree of renal insufficiency

Page 13: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

ACUTE RENAL FAILURE (CONT.)

Page 14: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE

• Outcome of the progressive and irrevocable loss of nephrons

• Progressive process: CKD – CRF – ESRD• A global health problem often linked with other

comorbidities, primarily hypertension and DM

Page 15: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

• Defined as decreased kidney function or kidney damage of 3 months’ duration based on blood tests, urinalysis, and imaging studies; GFR <60 ml/minute/1.73 m2 for 3 months with or without indication of damage to the kidney

Page 16: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

Risk Factors• Most commonly associated with DM,

hypertension, recurrent pyelonephritis, glomerulonephritis, and polycystic kidney disease

• Cause alterations in glomerular perfusion and filtration, sodium reabsorption, renal sympathetic activity, and activity of the RAAS

Page 17: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

Pathophysiology of Progression ofChronic Kidney Disease• Glomerulosclerosis and interstitial inflammation

and fibrosis• Monitored by two staging systems

• Percentage of nephron loss• Reduction in GFR

• GFR reduction occurs with nephron loss

Page 18: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

Page 19: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

Stages of Chronic Kidney Disease• Defined by level of function per GFR• Decreased renal reserve is not associated with

S/S of renal failure; interventions required to slow disease progression

• Renal insufficiency characterized by increase in metabolic wastes at levels proportional to nephron loss; polyuria

Page 20: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

Page 21: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

Complications of Chronic Kidney Disease• Hypertension and cardiovascular disease: due to

hypervolemia, escalated atherosclerotic process, heightened RAAS activity, and increased SNS activity

• Uremic syndrome: due to retention of metabolic wastes

• Metabolic acidosis: due to retention of acidic waste products; kidneys lose ability to secrete H+ ions and bicarbonate

Page 22: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

Complications of Chronic Kidney Disease• Electrolyte Imbalances: retention of potassium,

phosphorus, and magnesium in the blood• Renal osteodystrophy: elevated PTH causes

altered bone and mineral metabolism; kidneys unable to reabsorb calcium

Page 23: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CHRONIC KIDNEY DISEASE (CONT.)

• Malnutrition: decreased intake due to uremic syndrome, depression, dietary limitations, and changes in taste

• Anemia: due to lack of erythropoietin

Page 24: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CLINICAL MANAGEMENT

Prevention• Early identification of risk; addressing lifestyle

modifications and comorbidities• Maintenance of fluid volume status and cardiac

output• Avoid and monitor nephrotoxic chemicals• Avoid and aggressively treat infections

Page 25: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CLINICAL MANAGEMENT (CONT.)

Therapeutic Interventions• Slowing the progression of CKD is focus of

intervention until stage 4 or 5• Primary foci are appropriate management of ATN,

blood glucose control in diabetes, ACE inhibitors or AII blockers to reduce proteinuria, and aggressive management of hypertension and cardiovascular disease

Page 26: PathoPhysiology Chapter 28

Elsevier items and derived items © 2010, 2005 by Saunders, an imprint of Elsevier Inc.

CLINICAL MANAGEMENT (CONT.)

Therapeutic Interventions• Nutritional needs for patients with CKD include

increased calories, calcium, and vitamin supplementation

• Fluids, phosphorus, potassium, sodium, and protein intake are usually restricted

• Drug therapy for CKD is used to control hypertension, anemia, and some of the electrolyte imbalances